In Table 5, the relative difference between predicted and in vivo AUC values for the 110 µg dose is reported as 10.4%, yet this deviation appears substantial when considering clinical relevance. Could the authors clarify whether sensitivity analyses were conducted to assess how variations in key model parameters (e.g., dissolution rate or mucociliary clearance velocity) influence AUC predictions?